Page last updated: 2024-08-23

butaclamol and Parkinson Disease

butaclamol has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berl, S; Whetsell, WO; Winkler, MH; Yahr, MD	1
Arnold, G; Bandmann, O; Bondy, B; Gasser, T; Oertel, WH; Poewe, W; Schwarz, J; Trenkwalder, C; Wagner, M	1

Trials

1 trial(s) available for butaclamol and Parkinson Disease

Article	Year
3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes. Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:2 Topics: Adult; Aged; Butaclamol; Diagnosis, Differential; Double-Blind Method; Female; Humans; Kinetics; Levodopa; Lymphocytes; Male; Middle Aged; Parkinson Disease; Prospective Studies; Spiperone; Tremor	1993

Article

Year

3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes.

Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:2

Topics: Adult; Aged; Butaclamol; Diagnosis, Differential; Double-Blind Method; Female; Humans; Kinetics; Levodopa; Lymphocytes; Male; Middle Aged; Parkinson Disease; Prospective Studies; Spiperone; Tremor

1993

Other Studies

1 other study(ies) available for butaclamol and Parkinson Disease

Article	Year
Spiroperidol binding in the human caudate nucleus. Journal of neural transmission. Supplementum, 1980, Issue:16 Topics: Binding, Competitive; Butaclamol; Butyrophenones; Caudate Nucleus; Humans; In Vitro Techniques; Parkinson Disease; Spiperone; Synaptic Membranes	1980